Table_4_Propofol Inhibits Microglial Activation via miR-106b/Pi3k/Akt Axis.XLSX
Propofol is an established intravenous anesthetic agent with potential neuroprotective effects. In this study, we investigated the roles and the underlying mechanisms of propofol in inhibiting the pro-inflammatory responses of microglia. Propofol significantly reduced the messenger RNA (mRNA) levels of Tnf, Nos2, and NF-κB pathway related genes Ticam1, Myd88, Irf3, and Nfkb1 in lipopolysaccharide (LPS)-treated primary microglia. After screening the miRNA profiles in microglia under LPS and propofol treatment conditions, we found propofol abrogated the LPS-induced misexpression of miRNAs including miR-106b, miR-124, miR-185, and miR-9. Perturbation of function approaches suggested miR-106b as the core miRNA that mediated the anti-inflammatory effects of propofol on microglial activation. RNA sequencing (RNA-seq) analysis further identified Pi3k/Akt signaling as one of the most affected pathways after miR-106b perturbation of function. The treatment of Pi3k/Akt signaling agonist 740Y-P elevated miR-106b-reduced Akt phosphorylation and abolished the inhibitory effects of miR-106b on the pro-inflammatory responses of microglia. Our results suggest propofol inhibits microglial activation via miR-106b/Pi3k/Akt axis, shedding light on a novel molecular mechanism of propofol-mediated immunomodulatory effects and implying propofol as potential therapeutics for treating neuroinflammation-related neurodegenerative diseases.
History
References
- https://doi.org//10.1111/imm.12134
- https://doi.org//10.1038/nn.4132
- https://doi.org//10.1016/j.celrep.2016.02.042
- https://doi.org//10.1016/j.yexcr.2004.01.021
- https://doi.org//10.1016/j.intimp.2016.05.007
- https://doi.org//10.3389/fncel.2014.00279
- https://doi.org//10.1016/j.jstrokecerebrovasdis.2017.08.017
- https://doi.org//10.1097/01.anes.0000278892.62305.9c
- https://doi.org//10.1111/jcmm.15698
- https://doi.org//10.3389/fncel.2019.00264
- https://doi.org//10.3389/fnmol.2019.00125
- https://doi.org//10.1016/j.jcrc.2019.12.021
- https://doi.org//10.1126/science.1113329
- https://doi.org//10.1016/j.jneuroim.2019.05.003
- https://doi.org//10.5114/fn.2017.68579
- https://doi.org//10.1016/j.mcp.2019.101470
- https://doi.org//10.1097/wnr.0000000000001041
- https://doi.org//10.2174/1381612043382846
- https://doi.org//10.1016/j.bbi.2014.07.002
- https://doi.org//10.1007/s00011-014-0713-9
- https://doi.org//10.3109/08923973.2012.665461
- https://doi.org//10.3233/jad-132792
- https://doi.org//10.1016/s1474-4422(13)70090-5
- https://doi.org//10.3390/cells8111465
- https://doi.org//10.1016/j.jneuroim.2018.11.010
- https://doi.org//10.3892/etm.2017.4874
- https://doi.org//10.1073/pnas.1501441112
- https://doi.org//10.18632/aging.104104
- https://doi.org//10.1146/annurev-physiol-022516-034406
- https://doi.org//10.1016/j.bmcl.2009.04.032
- https://doi.org//10.1016/j.imlet.2016.12.003
- https://doi.org//10.1007/s10753-017-0658-6